Thomas A Schmidt, Clifford J Rosen, John S Yudkin. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Cardiovascular Diseases/chemically inducedDiabetes Mellitus, Type 2/drug therapyDrug ApprovalEuropeEuropean UnionFemaleGovernment AgenciesHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsInsulin, Long-Acting/administration & dosageInsulin, Long-Acting/adverse effectsMaleProduct Surveillance, PostmarketingPublic HealthUnited StatesUnited States Food and Drug Administration
Substances： See more » Hypoglycemic AgentsInsulin, Long-Actinginsulin degludec
Year: 2013 PMID： 23757746 DOI： 10.1136/bmj.f3731
Source DB: PubMed Journal: BMJ ISSN： 0959-8138